Home / Market News / $MBRX

$MBRX news and market catalysts

The 3 most recent market catalysts affecting $MBRX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 2 high impact 0 bullish 3 bearish Biotechnology

Aug 14, 2026 Corporate Catalyst Bearish Impact 92

Moleculin Biotech Q2 EPS $(1.40) Misses $(1.01) Estimate

Moleculin Biotech (MBRX) announced Q2 earnings per share of $(1.40), which was a substantial miss compared to the analyst consensus estimate of $(1.01). This 38.61% deviation from …

Jul 31, 2026 Corporate Catalyst Bearish Impact 95

Moleculin Biotech Stock Is Sinking Friday: What's Going On?

Moleculin Biotech (MBRX) experienced a sharp decline in its stock price after announcing a $9.3 million public offering priced at a substantial discount (75 cents per share) compar…

Jul 31, 2026 Corporate Catalyst Bearish Impact 75

Moleculin Biotech shares are trading lower after the company announced it priced a $9.3 million public offering.

The announcement of a public offering, especially one of this size relative to the company's market capitalization, is a significant corporate catalyst. The primary impact is negat…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.